941
Participants
Start Date
June 27, 2019
Primary Completion Date
December 29, 2021
Study Completion Date
August 11, 2022
Placebo
Placebo
Nemolizumab
Nemolizumab
Galderma Investigational Site 6194, Vienna
Galderma Investigational Site 6158, Vienna
Galderma Investigational Site 5441, Darlinghurst
Galderma Investigational Site 6152, Westmead
Galderma Investigational Site 5759, Kogarah
Galderma Investigational Site 5366, East Melbourne
Galderma Investigational Site 5458, Parkville
Galderma Investigational Site 6131, Carlton
Galderma Investigational Site 6119, Hamilton
Galderma Investigational Site 6161, Brisbane
Galderma Investigational Site 5638, Benowa
Galderma Investigational Site 6159, Woodville
Galderma Investigational Site 6118, Wellington
Galderma Investigational Site 6153, Victoria Park
Galderma Investigational Site 5453, Fremantle
Galderma Investigational Sites 6157, Graz
Galderma Investigational Site 5580, Barcelona
Galderma Investigational Site 6212, Groningen
Galderma Investigational Site 8620, New York
Galderma Investigational Site 8279, New York
Galderma Investigational Site 6021, Prague
Galderma Investigational Site 8242, Brooklyn
Galderma Investigational Site 6172, Berlin
Galderma Investigational Site 6110, Berlin
Galderma Investigational Site 6095, Bucheon-si
Galderma Investigational Site 6098, Gyeonggi-do
Galderma Investigational Site 6154, Gyeonggi-do
Galderma Investigational Site 8255, Philadelphia
Galderma Investigational Site 8802, Plymouth Meeting
Galderma Investigational Site 6138, Incheon
Galderma Investigational Site 6120, Incheon
Galderma Investigational Site 6066, Buxtehude
Galderma Investigational Site 8862, Fairfax
Galderma Investigational Site 6093, Incheon
Galderma Investigational Site 5437, Kiel
Galderma Investigational Site 6058, Madrid
Galderma Investigational Site 5842, Madrid
Galderma Investigational Site 6190, Madrid
Galderma Investigational Site 6036, Madrid
Galderma Investigational Site 8648, Wilmington
Galderma Investigational Site 5551, Madrid
Galderma Investigational Site 8736, Charleston
Galderma Investigational Site 8728, Newnan
Galderma Investigational Site 8887, Union City
Galderma Investigational Site 6191, Pamplona
Galderma Investigational Site 8744, Macon
Galderma Investigational Site 8711, Jacksonville
Galderma Investigational Site 8806, Miami Lakes
Galderma Investigational Site 8804, Hialeah
Galderma Investigational Site 8800, Miami Lakes
Galderma Investigational Site 8734, Pembroke Pines
Galderma Investigational Site 8902, Doral
Galderma Investigational Site 8710, Miami
Galderma Investigational Site 8801, Miami
Galderma Investigational Site 8737, Miami
Galderma Investigational Site 8708, Miami
Galderma Investigational Site 8897, Brandon
Galderma Investigational Site 6061, Bielefeld
Galderma Investigational Site 8805, Cape Coral
Galderma Investigational Site 6106, Las Palmas de Gran Canaria
Galderma Investigational Site 8771, Louisville
Galderma Investigational Site 8595, Dublin
Galderma Investigational Site 8702, Bexley
Galderma Investigational Site 8142, Indianapolis
Galderma Investigational Site 8155, Troy
Galderma Investigational Site 8743, Ann Arbor
Galderma Investigational Site 6039, Münster
Galderma Investigational Site 8748, Ypsilanti
Galderma Investigational Site 6028, Dülmen
Galderma Investigational Site 6022, Bad Bentheim
Galderma Investigational Site 8512, Bay City
Galderma Investigational Site 5918, Osnabrück
Galderma Investigational Site 6100, Busan
Galderma Investigational Site 8818, Rapid City
Galderma Investigational Site 8718, Missoula
Galderma Investigational Site 8571, Skokie
Galderma Investigational Site 8712, Skokie
Galderma Investigational Site 5368, Darmstadt
Galderma Investigational Site 8521, Saint Joseph
Galderma Investigational Site 8810, Omaha
Galderma Investigational Site 6109, Stuttgart
Galderma Investigational Site 6214, Tübingen
Galderma Investigational Site 8880, North Little Rock
Galderma Investigational Site 8206, Norman
Galderma Investigational Site 8857, Oklahoma City
Galderma Investigational Site 8664, Frisco
Galderma Investigational Site 8238, Dallas
Galderma Investigational Site 8133, Arlington
Galderma Investigational Site 8042, Houston
Galderma Investigational Site 8827, Dripping Springs
Galderma Investigational Site 8890, Blackfoot
Galderma Investigational Site 8819, Nampa
Galderma Investigational Site 8740, Henderson
Galderma Investigational Site 6146, Langenau
Galderma Investigational Site 8674, Los Angeles
Galderma Investigational Site 8608, Santa Monica
Galderma Investigational Site 8578, Cerritos
Galderma Investigational Site 8686, Lomita
Galderma Investigational Site 8895, Santa Ana
Galderma Investigational Site 8636, Fountain Valley
Galderma Investigational Site 8888, Fullerton
Galderma Investigational Site 8125, San Francisco
Galderma Investigational Site 8882, Bangor
Galderma Investigational Site 8085, Calgary
Galderma Investigational Site 8903, Calgary
Galderma Investigational Site 8215, Calgary
Galderma Investigational Site 8088, Edmonton
Galderma Investigational Site 8824, Edmonton
Galderma Investigational Site 8722, Edmonton
Galderma Investigational Site 8161, Surrey
Galderma Investigational Site 8586, Barrie
Galderma Investigational Site 8904, Guelph
Galderma Investigational Site 8901, Ottawa
Galderma Investigational Site 8336, Toronto
Galderma Investigational Site 8899, Toronto
Galderma Investigational Site 8780, Niagara Falls
Galderma Investigational Site 8610, Ottawa
Galderma Investigational Site 8000, Saint John
Galderma Investigational Site 8731, Waterloo
Galderma Investigational Site 6055, Brno
Galderma Investigational Site 5225, Náchod
Galderma Investigational Site 6030, Olomouc
Galderma Investigational Site 6024, Prague
Galderma Investigational Site 6054, Prague
Galderma Investigational Site 6240, Prague
Galderma Investigational Site 6025, Prague
Galderma Investigational Site 6113, Liepāja
Galderma Investigational Site 6134, Riga
Galderma Investigational Site 6059, Riga
Galderma Investigational Site 6060, Talsi
Galderma Investigational Site 6111, Kaunas
Galderma Investigational Site 6072, Klaipėda
Galderma Investigational Site 6112, Vilnius
Galderma Investigational Site 6108, Rotterdam
Galderma Investigational Site 6027, Utrecht
Galderma Investigational Site 6255, Częstochowa
Galderma Investigational Site 6075, Gdansk
Galderma Investigational Site 6243, Gdansk
Galderma Investigational Site 5138, Gdansk
Galderma Investigational Site 6244, Gdynia
Galderma Investigational Site 6087, Katowice
Galderma Investigational Site 6245, Lodz
Galderma Investigational Site 5570, Lodz
Galderma Investigational Site 6231, Lodz
Galderma Investigational Site 6071, Lublin
Galderma Investigational Site 6237, Ostrowiec Świętokrzyski
Galderma Investigational Site 6127, Poznan
Galderma Investigational Site 6223, Szczecin
Galderma Investigational Site 6065, Warsaw
Galderma Investigational Site 6122, Warsaw
Galderma Investigational Site 6242, Warsaw
Galderma Investigational Site 6064, Warsaw
Galderma Investigational Site 6222, Warsaw
Galderma Investigational Site 6047, Wroclaw
Galderma Investigational Site 5005, Wroclaw
Galderma Investigational Site 6105, Seoul
Galderma Investigational Site 5659, Seoul
Galderma Investigational Site 6116, Seoul
Galderma Investigational Site 6129, Seoul
Galderma Investigational Site 6103, Seoul
Galderma Investigational Site 6056, Seoul
Galderma Investigational Site 6094, Seoul
Galderma Investigational Site 6099, Seoul
Galderma Investigational Site 6057, Alicante
Galderma Investigational Site 6037, Barcelona
Galderma Investigational Site 6035, Barcelona
Galderma Investigational Site 6202, Barnsley
Galderma Investigational Site 6207, Blackpool
Galderma Investigational Site 6203, Cannock
Galderma Investigational Site 6104, Glasgow
Galderma Investigational Site 6204, Liverpool
Galderma Investigational Site 6121, London
Galderma Investigational Site 6205, Manchester
Galderma Investigational Site 6206, Stockton-on-Tees
Lead Sponsor
Galderma R&D
INDUSTRY